Skip to content
Screener

Mesa Laboratories MLAB Clinical Genomics — Cost Of Revenue Other

Similar metrics at other companies

SRT
SRTAClinical — Cost of revenue
$14.83M
SRT
SRTAOther Clinical — Revenue
$9.95M
Tempus AI, Inc. logo
TEMGenomics Product — Revenue
$21.8M+77.2%
Neogen logo
NEOGGenomics Services — Revenue
$22.8M+0.4%
SRT
SRTAClinical — Revenue
$19.79M
WW International, Inc. logo
WWClinical Subscription Revenues — Revenue
$39.91M+38.3%

Other financials

Income statement

See full
Revenue$60.1M+1.0%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$2.8M-40.3%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$30.7M+44.3%
Total debt$78.5M-52.9%
Total equity$188.8M+9.4%
Total assets$419.2M-3.8%

Cash flow

See full
Operating cash flow$14.7M+678%
CapEx$559.0K-44.6%
Free cash flow$14.2M+1,504%

Valuation

See full
Market cap$574.42M+70.9%
Enterprise value$622.2M+28.9%
P/E42×
P/S2.3×+0.9×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin21.2%+7.3pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.8×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept mlab:CostOfRevenueOther.

The source filing: Mesa Laboratories’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 5:17 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001437749-26-026808
Three months ended June 30, 2026Sterilization and Disinfection ControlBiopharmaceutical DevelopmentCalibration SolutionsClinical GenomicsTotal
Less
Depreciation in cost of revenue43778111119745
Amortization in cost of revenue121379-191691
Other cost of revenue (b)6,7884,0205,1433,73919,690
Total segment cost of revenue7,3464,4775,2544,04921,126
Gross Profit (c)$17,159$7,582$8,031$6,240$39,012
Reconciling items:
Operating expense$31,981

Document

FAQ

What is Mesa Laboratories's clinical genomics — cost of revenue other?
Mesa Laboratories (MLAB) reported clinical genomics — cost of revenue other of $3.74M in Q2 2026.
How has Mesa Laboratories's clinical genomics — cost of revenue other changed year-over-year?
Mesa Laboratories's clinical genomics — cost of revenue other decreased by 17.2% year-over-year, from $4.52M to $3.74M.
What is the long-term trend for Mesa Laboratories's clinical genomics — cost of revenue other?
Over 2 years (2024 to 2026), Mesa Laboratories's clinical genomics — cost of revenue other has grown at a -5.4% compound annual growth rate (CAGR), from $20.13M to $18.02M.
What does clinical genomics — cost of revenue other mean?
This captures direct production costs within the Clinical Genomics segment that are not classified as depreciation or amortization. It typically includes raw materials, direct labor, and variable overhead necessary to deliver the segment's products and services.

Ask your AI about Mesa Laboratories's clinical genomics — cost of revenue other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude